Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2001-6-21
pubmed:abstractText
We previously demonstrated that administration of plasmid DNAs (pDNAs) encoding IL-4 and a fragment of glutamic acid decarboxylase 65 (GAD65) fused to IgGFc induces GAD65-specific Th2 cells and prevents insulin-dependent diabetes mellitus (IDDM) in nonobese diabetic (NOD) mice. To assess the general applicability of pDNA vaccination to mediate Ag-specific immune deviation, we examined the immunotherapeutic efficacy of recombinants encoding murine insulin A and B chains fused to IgGFc. Insulin was chosen based on studies demonstrating that administration of insulin or insulin B chain by a variety of strategies prevents IDDM in NOD mice. Surprisingly, young NOD mice receiving i.m. injections of pDNA encoding insulin B chain-IgGFc with or without IL-4 exhibited an accelerated progression of insulitis and developed early diabetes. Exacerbation of IDDM correlated with an increased frequency of IFN-gamma-secreting CD4(+) and CD8(+) T cells in response to insulin B chain-specific peptides compared with untreated mice. In contrast, treatment with pDNAs encoding insulin A chain-IgGFc and IL-4 elicited a low frequency of IL-4-secreting Th cells and had no effect on the progression of IDDM. Vaccination with pDNAs encoding GAD65-IgGFc and IL-4, however, prevented IDDM. These results demonstrate that insulin- and GAD65-specific T cell reactivity induced by pDNA vaccination has distinct effects on the progression of IDDM.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
167
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
586-92
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:11418698-Aging, pubmed-meshheading:11418698-Animals, pubmed-meshheading:11418698-CD4-Positive T-Lymphocytes, pubmed-meshheading:11418698-CD8-Positive T-Lymphocytes, pubmed-meshheading:11418698-Diabetes Mellitus, Type 1, pubmed-meshheading:11418698-Disease Progression, pubmed-meshheading:11418698-Epitopes, T-Lymphocyte, pubmed-meshheading:11418698-Female, pubmed-meshheading:11418698-Glutamate Decarboxylase, pubmed-meshheading:11418698-Immunoglobulin Fc Fragments, pubmed-meshheading:11418698-Immunoglobulin G, pubmed-meshheading:11418698-Injections, Intramuscular, pubmed-meshheading:11418698-Insulin, pubmed-meshheading:11418698-Interleukin-4, pubmed-meshheading:11418698-Isoenzymes, pubmed-meshheading:11418698-Lymphocyte Activation, pubmed-meshheading:11418698-Lymphocyte Count, pubmed-meshheading:11418698-Mice, pubmed-meshheading:11418698-Mice, Inbred NOD, pubmed-meshheading:11418698-Plasmids, pubmed-meshheading:11418698-Recombinant Fusion Proteins, pubmed-meshheading:11418698-Th1 Cells, pubmed-meshheading:11418698-Vaccines, DNA
pubmed:year
2001
pubmed:articleTitle
Plasmid DNAs encoding insulin and glutamic acid decarboxylase 65 have distinct effects on the progression of autoimmune diabetes in nonobese diabetic mice.
pubmed:affiliation
Department of Microbiology and Immunology, School of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.